Adenovirus-mediated overexpression of human transforming growth factor- β1 in rat cardiac fibroblasts, myocytes and smooth muscle cells

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 4, 1996, Pages 735-742

  Villarreal, Francisco J ^a   Lee, A A ^a   Dillmann, W H ^a   Giordano, F J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; Fibrosis; Gene therapy; Growth factors; Remodeling

Indexed keywords

BETA ACTIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; FIBROBLAST; GENE TRANSFER; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN ADENOVIRUS 5; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ANIMALS; BLOTTING, NORTHERN; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYPERTROPHY; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030007251     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0068     Document Type: Article

References (23)

1. ALLEN-HOFFMANN BL, CRANKSHAW CL, MOSHER DF, 1988. Transforming growth factor β increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol 8: 4234-4242.
2. BARR E, CARROLL J, KALYNYCH AM, TRIPATHY SK, KOZARSKY K, WILSON JM, LEIDEN JM, 1994. Efficient catheter mediated gene transfer into the heart using replication defective adenovirus. Gene Ther 1: 51-58.
3. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y PIERSCHBACHER MD, RUOSLAHTI E, 1992. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360: 361-366.
4. CASSCELLS W, BAZOBERRY F, SPEIR E, THOMPSON N, FLANDERS K, KONDAIAH P, FERRANS VJ, EPSTEIN SE, SPORN M, 1990. Transforming growth factor beta 1 in normal heart and in myocardial infarction. Ann New York Acad Sci 593: 148-160.
5. CSETE ME, DRAZAN KE, VAN BREE M, MCINTEE DF, MCBRIDE WH, BETT A, GRAHAM FL, BUSUTTIL RW, BERK AJ, SHADEK A, 1994. Adenovirus mediated gene transfer in the transplant setting. I. Conditions for expression of transferred genes in col-preserved hepatocytes. Transplantation 57: 1502-1507.
6. CHANG MW, BARR E, SELTZER J, JIANG YQ, NABEL GJ, NABEL EG, PARMACEK MS, LEIDEN JM, 1995. Cytostatic gene therapy for vascular proliferative disorders with constitutively active form of the retinoblastoma gene product. Science 267: 518-522.
7. 1 and phorbol myristate acetate on cardiac fibroblasts; Regulation of fibrillar collagen mRNA's and expression of early transcription factors. Circ Res 69: 483-490.
8. FLAUMENHAFT R, ABE M, SATO Y MIYASONO K, HARPEL J, HELDIN CH, RIFKIN DB, 1993. Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol 120: 995-1002.
9. GLEMBOTSKI CC, IRONS CE, KROWN KA, MURRAY SF, SPRENKLE AB, SEI CA, 1993. Myocardial alpha thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression. J Biol Chem 268: 20646-20652.
10. GIBBONS GH, PRATT RE, DZAU VJ, 1992. Vascular smooth muscle cell hypertrophy vs. hyperplasia: Autocrine transforming growth factor-b1 expression determines growth response to angiotensin II. J Clin Invest 90: 456-461.
11. GOMEZ-FOIX AM, COATS WS, BAQUE S, ALAM T, GERARD RD, NEWGARD CB, 1992. Adenovirus mediated transfer of the muscle glycogen phosphorilase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem 267: 25129-25134.
12. IGNOTZ RA, MASSAGUE J, 1986. Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337-4345.
13. KIRSHENBAUM LA, MACLELLAN WR, MAZUR W, FRENCH BA, SCHNEIDER M, 1993. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest 92: 381-387.
14. LEE AA, DILLMANN WH, MCCULLOCH AD, VILLARREAL FJ, 1995. Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27: 2347-2357.
15. PAIEMENT R, BONAN R, CLOUTIER MJ, LEUNG TK, 1994. Intramural delivery of anti-transforming growth factor beta antibodies does not prevent coronary restenosis in a swine model. FASEB J 8: A310.
16. QIAN SW, KONDAIAH P, CASSCELLS W, ROBERTS AB, SPIORN MB, 1991. A second messenger RNA species of transforming growth factor beta 1 in infarcted rat heart. Cell Regulation 2: 241-249.
17. ROBERTS AB, VODOVOTZ Y, ROCHE NS, SPORN MB, NATHAN CF, 1992. Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes. Mol Endocrinol 6: 1921-1930.
18. 2+ ATPase and myosin heavy chain α gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not retinoic acid. J Biol Chem 266: 8638-8646.
19. SPORN MB, ROBERTS AB, WAKEFIELD LM, ASSOSIAN RK, 1986. Transforming growth factor-β: histological function and chemical structure. Science 233: 532-534.
20. VILLARREAL FJ, DILLMANN WH, 1992. Cardiac hypertrophy induced changes in mRNA levels for TGFβ1, fibronectin and collagens. Am J Physiol 262: H1861-H1866.
21. 1) receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861.
22. WALTENBERGER J, WANDERS A, FELLSTROM B, MIYAZONO K, HELDIN CH, FUNA K, 1993. Induction of TGF-beta during cardiac allograft rejection. J Immunol 151: 1147-1157.
23. WALTENBERGER J, LUNDIN L, OBERG K, WILANDER E, MIYAZONO K, HELDIN CH, FUNA K, 1993. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 142: 71-78.